MacroGenics
MD - RockvilleBiotechnology
Focus: MacroGenics is a clinical-stage biotechnology company headquartered in Rockville, MD, specializing in bispecific antibodies for oncology. The company has one FDA-approved product (MARGENZA) in peak commercialization with a robust pipeline of 30 oncology and immunology programs.
Profile data last refreshed 53m ago · AI intelligence enriched 3w ago
Open Jobs
0
About MacroGenics
AI assessmentNot HiringNo open roles listed right now. Follow MacroGenics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak
Only FDA-approved product; HER2/Neu antagonist generating company revenue and clinical proof-of-concept for bispecific platform.
Products & Portfolio (1)
Help build intelligence for MacroGenics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.